Toripalimab plus axitinib versus sunitinib as first-line treatment for advanced renal cell carcinoma: RENOTORCH, a randomized, open-label, phase III study
Titel:
Toripalimab plus axitinib versus sunitinib as first-line treatment for advanced renal cell carcinoma: RENOTORCH, a randomized, open-label, phase III study
Auteur:
Yan, X.Q. Ye, M.J. Zou, Q. Chen, P. He, Z.S. Wu, B. He, D.L. He, C.H. Xue, X.Y. Ji, Z.G. Chen, H. Zhang, S. Liu, Y.P. Zhang, X.D. Fu, C. Xu, D.F. Qiu, M.X. Lv, J.J. Huang, J. Ren, X.B. Cheng, Y. Qin, W.J. Zhang, X. Zhou, F.J. Ma, L.L. Guo, J.M. Ding, D.G. Wei, S.Z. He, Y. Guo, H.Q. Shi, B.K. Liu, L. Liu, F. Hu, Z.Q. Jin, X.M. Yang, L. Zhu, S.X. Liu, J.H. Huang, Y.H. Xu, T. Liu, B. Sun, T. Wang, Z.J. Jiang, H.W. Yu, D.X. Zhou, A.P. Jiang, J. Luan, G.D. Jin, C.L. Xu, J. Hu, J.X. Huang, Y.R. Guo, J. Zhai, W. Sheng, X.N.
Verschenen in:
Annals of oncology
Paginering:
Jaargang 35 () nr. 2 pagina's 190-199
Jaar:
2024
Inhoud:
Uitgever:
X. Yan, M. Ye, Q. Zou, P. Chen, Z. He, B. Wu, D. He, C. He, X. Xue, Z. Ji, H. Chen, S. Zhang, Y. Liu, X. Zhang, C. Fu, D. Xu, M. Qiu, J. Lv, J. Huang, X. Ren, Y. Cheng, W. Qin, X. Zhang, F. Zhou, L. Ma, J. Guo, D. Ding, S. Wei, Y. He, H. Guo, B. Shi, L. Liu, F. Liu, Z. Hu, X. Jin, L. Yang, S. Zhu, J. Liu, Y. Huang, T. Xu, B. Liu, T. Sun, Z. Wang, H. Jiang, D. Yu, A. Zhou, J. Jiang, G. Luan, C. Jin, J. Xu, J. Hu, Y. H, Jun, W. Zhai, X. Sheng, Shanghai Junshi Biosciences Co. LTD, Shanghai Junshi Biosciences Co. LTD., a